DNA icon

OFD1-Related Disorders via the OFD1 Gene

Summary and Pricing

Test Method

Exome Sequencing with CNV Detection
Test Code Test Copy GenesTest CPT Code Gene CPT Codes Copy CPT Codes Base Price
OFD1 81479 81479,81479 $990
Test Code Test Copy Genes Test CPT Code Gene CPT Codes Copy CPT Code Base Price
11541OFD181479 81479,81479 $990 Order Options and Pricing

Pricing Comments

Our favored testing approach is exome based NextGen sequencing with CNV analysis. This will allow cost effective reflexing to PGxome or other exome based tests. However, if full gene Sanger sequencing is desired for STAT turnaround time, insurance, or other reasons, please see link below for Test Code, pricing, and turnaround time information. If the Sanger option is selected, CNV detection may be ordered through Test #600.

An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.

Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).

Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).

The Sanger Sequencing method for this test is NY State approved.

For Sanger Sequencing click here.

Turnaround Time

3 weeks on average for standard orders or 2 weeks on average for STAT orders.

Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.

Targeted Testing

For ordering sequencing of targeted known variants, go to our Targeted Variants page.

EMAIL CONTACTS

Genetic Counselors

Geneticist

  • Fang Xu, PhD, FACMG

Clinical Features and Genetics

Clinical Features

Oral-Facial-Digital syndrome type 1 (OFD1) is a developmental disorder with variable expressivity characterized by oral anomalies (lobed tongue, cleft palate, gingival frenulae, dental abnormalities); facial anomalies (ocular hypertelorism, hypoplasia of the alae nasi, upper lip median cleft, micrognathia); digital anomalies (brachydactyly, syndactyly, clinodactyly; preaxial or postaxial polydactyly, duplicated hallux); brain anomalies (intracerebral cysts, corpus callosum agenesis, cerebellar agenesis with or without Dandy-Walker malformation) and polycystic kidneys. In addition, about 50% of patients diagnosed with OFD1 have learning disabilities (Gorlin and Psaume 1962; Feather et al. 1997; Ferrante et al. 2001).

Joubert Syndrome (JBTS) is marked by mid-hindbrain malformation, retinal dystrophy, cystic renal disease, hepatic fibrosis and polydactyly (Doherty 2009). Mid-hindbrain malformation, which can be readily identified as a “Molar Tooth Sign” (MTS) using Magnetic Resonance Imaging (MRI), typically leads to hypotonia, ataxia, abnormal eye movements and intellectual disability. MTS is pathognomonic for JBTS.

Retinitis Pigmentosa is an inherited degenerative disease of the retina characterized by abnormalities of the photoreceptors or the retinal pigment epithelium. It is a progressive disease. Symptoms usually begin with night blindness, progressing to constriction of the peripheral visual field and, eventually, to loss of central vision. The age of onset varies from childhood to middle age (Gu et al. 1999).

Genetics

OFD1 is embryonic male-lethal X-linked dominant condition caused by pathogenic variants in the OFD1 gene (Feather et al. 1997; Ferrante et al. 2001). OFD1 encodes oral-facial-digital syndrome 1 protein (OFD1), which is localized to centrosomes and basal bodies of ciliated cells suggesting a role in cilia motility and function (Ferrante et al. 2009; Coene et al. 2009). A mix of missense, nonsense, frameshift and splicing variants as well as gross deletions have been reported in OFD1 (Ferrante et al. 2001; Rakkolainen et al. 2002; Morisawa et al. 2004; Budny et al. 2006; Coene et al. 2009). Roughly 75% of OFD1 cases are simplex (Toriello and Franco 2013). Severity of the phenotype correlates with the reduction in protein length (Thauvin-Robinet et al. 2006). Coene et al. predicted that all pathogenic variants before residue 631 are lethal for males and cause OFD I syndrome in females, while males with JBS10 who may live beyond the age of 30 years have pathogenic variants located in the coiled-coil domain nearest to the C terminus (Coene et al. 2009).

Clinical Sensitivity - Sequencing with CNV PGxome

Roughly 80% of females with OFD1 syndrome are found to have OFD1 pathogenic variant detected by sequencing (Prattichizzo et al. 2008). Approximately 5% of females with OFD1 syndrome will have a gross deletion (Thauvin-Robinet et al 2009). The clinical sensitivity for Joubert syndrome, Simpson-Golabi-Behmel syndrome, and retinitis pigmentosa is unknown due to the paucity of documented cases. Analytical sensitivity should be high for Joubert syndrome, Simpson-Golabi-Behmel syndrome, and retinitis pigmentosa since all OFD1 pathogenic variants reported to date are expected to be detected by sequencing.

Roughly 20% of individuals with OFD1 syndrome who have a negative finding by sequencing have been found to have a gross deletion in OFD1 (Thauvin-Robinet et al. 2009).

Testing Strategy

This test provides full coverage of all coding exons of the OFD1 gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).

We also sequence the intronic c.935+706A>G variant (Webb et al. 2012).

Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).

Indications for Test

Candidates for this test are patients with symptoms consistent with X-linked dominant OFD1, and X-linked recessive Simpson-Golabi-Behmel syndrome type 2, Joubert syndrome 10, and retinitis pigmentosa, and family members of patients who have known OFD1 variants.

Gene

Official Gene Symbol OMIM ID
OFD1 300170
Inheritance Abbreviation
Autosomal Dominant AD
Autosomal Recessive AR
X-Linked XL
Mitochondrial MT

Citations

  • Budny et al. 2006. PubMed ID: 16783569
  • Coene K.L. et al. 2009. American Journal of Human Genetics. 85: 465-81. PubMed ID: 19800048
  • Doherty. 2009. PubMed ID: 19778711
  • Feather S.A. et al. 1997. Human Molecular Genetics. 6: 1163-7. PubMed ID: 9215688
  • Ferrante M.I. et al. 2001. American Journal of Human Genetics. 68: 569-76. PubMed ID: 11179005
  • Ferrante M.I. et al. 2009. Human Molecular Genetics. 18: 289-303. PubMed ID: 18971206
  • Gorlin R.J., Psaume, J. 1962. The Journal of Pediatrics. 61: 520-30. PubMed ID: 13900550
  • Gu S. et al. 1999. Journal of Medical Genetics. 36: 705-7. PubMed ID: 10507729
  • Morisawa T. et al. 2004. Human Genetics. 115: 97-103. PubMed ID: 15221448
  • Prattichizzo C. et al. 2008. Human Mutation. 29: 1237-46. PubMed ID: 18546297
  • Rakkolainen A. et al. 2002. Journal of Medical Genetics. 39: 292-6. PubMed ID: 11950863
  • Thauvin-Robinet C. et al. 2006. Journal of Medical Genetics. 43: 54-61. PubMed ID: 16397067
  • Thauvin-Robinet C. et al. 2009. Human Mutation. 30: E320-9. PubMed ID: 19023858
  • Toriello H.V, Franco B. 2013. Oral-Facial-Digital Syndrome Type I. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong C-T, Smith RJ, and Stephens K, editors. GeneReviews™, Seattle (WA): University of Washington, Seattle. PubMed ID: 20301367
  • Webb T. R. et al. 2012. Human Molecular Genetics. 21: 3647-54. PubMed ID: 22619378

Ordering/Specimens

Ordering Options

We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.

myPrevent - Online Ordering

  • The test can be added to your online orders in the Summary and Pricing section.
  • Once the test has been added log in to myPrevent to fill out an online requisition form.
  • PGnome sequencing panels can be ordered via the myPrevent portal only at this time.

Requisition Form

  • A completed requisition form must accompany all specimens.
  • Billing information along with specimen and shipping instructions are within the requisition form.
  • All testing must be ordered by a qualified healthcare provider.

For Requisition Forms, visit our Forms page

If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.


Specimen Types

Specimen Requirements and Shipping Details

PGxome (Exome) Sequencing Panel

PGnome (Genome) Sequencing Panel

loading Loading... ×

ORDER OPTIONS

An error has occurred while calculating the price. Please try again or contact us for assistance.

View Ordering Instructions

1) Select Test Method (Platform)


1) Select Test Type


2) Select Additional Test Options

No Additional Test Options are available for this test.

Note: acceptable specimen types are whole blood and DNA from whole blood only.
Total Price: loading
Patient Prompt Pay Price: loading
A patient prompt pay discount is available if payment is made by the patient and received prior to the time of reporting.
Show Patient Prompt Pay Price
×
Copy Text to Clipboard
×